Farmoquímica

What Farmoquímica does

Farmoquímica S.A. ("FQM" or "FQM Grupo") is a privately held Brazilian pharmaceutical company founded in 1932 and headquartered in Rio de Janeiro, with approximately 1,600 employees across a matrix office, a manufacturing plant in Jacaré (RJ), sales offices in São Paulo and Recife, and a distribution center in Campina Grande. The company operates three business divisions organized by go-to-market: FQM FARMA distributes prescription drugs across pediatrics, cardiology, gynecology, orthopedics, otolaryngology, angiology, and CNS via more than 450 medical representatives nationwide; FQM MELORA markets dermatological products including dermocosmetics, nutraceuticals, and prescription dermatology through 108 representatives reaching more than 12,000 doctors monthly; and FQM DIVCOM sells OTC and self-care consumer products through Brazilian pharmacy chains and e-commerce partners.

The technology base centers on in-house pharmaceutical manufacturing and proprietary or exclusively licensed dermatological formulations. Notable proprietary assets include the patented SILICLEAR COMPLEX molecule used in the Kelo-cote silicone scar-treatment gel, spray, and SPF-30 variants, and the Fernblock (Polypodium leucotomos extract) used in Heliocare topical sunscreens and Helioral oral photoprotection supplements. The commercial portfolio spans 50+ branded SKUs covering prescription medications (Bactrim, Roacutan, Marevan, Ixium, Abretia, Alendil, Annita, Actifedrin, Belpele, Dormonid, Floratil, Prefiss, Rohypnol), dermocosmetics (Heliocare, Heliomax, Kelo-cote, Tensage, Melora C, Dercutan, Dermovance, Duo Retix, Eximia), and OTC consumer health (Imecap, Calcitran, Fledoid, Floratil, Fumasil, Sedavan, Melatol, Lipomax, Fumagum). All products are registered with ANVISA, the Brazilian health regulatory authority, with active pharmacovigilance, technovigilance, cosmetovigilance, and nutrivigilance programs.

The revenue model is a unit-sale-based B2B/B2C hybrid. Prescription revenue under FQM FARMA depends on physician recommendations secured through field-force detailing and scientific congress participation. FQM MELORA combines physician-driven prescription (Roacutan, Ixium, Heliocare, Kelo-cote medical positioning) with consumer pull-through in pharmacies and pharmacy e-commerce platforms. FQM DIVCOM operates a direct-to-consumer motion through pharmacy chains without prescription requirements. Customer concentration is structurally diluted: pharmacy retail distribution spans major Brazilian chains, the prescriber base numbers in the tens of thousands, and consumer demand flows through a long tail of branded OTC SKUs. Strategic direction since the 2016 acquisition of Melora has emphasized dermatology consolidation, nutricosmetics, and disciplined ANVISA-driven product line extensions across all three divisions.

Name

Farmoquímica

Legal name

Farmoquímica S.A

Website

https://fqmgrupo.com.br

Company type

Private

Founded year

1932

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Farmoquímica is a privately held Brazilian pharmaceutical company founded in 1932, operating three divisions — FQM FARMA (prescription drugs), FQM MELORA (dermatology and dermocosmetics), and FQM DIVCOM (OTC consumer health) — distributed through 558+ medical representatives and pharmacy chains across Brazil.

Ownership category

akta.pro rank

Product category

Pharmaceuticals

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

akta.pro secondary industry

Probiotics & Digestive Health Supplements (CRADAGAF)

Keywords

• Prescription pharmaceuticals
• Dermocosmetic products
• Over-the-counter medicines
• Nutraceutical supplements
• Dermatological products

Headquarters

HQ city

Rio De Janeiro

HQ country

Brazil

HQ region

Latin America

Offices5 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Prescription Medicines (FARMA): Prescription-based ethical pharmaceuticals sold through medical representatives and pharmacy chains, covering specialties including Pediatrics, Angiology, Cardiology, Gynecology, Orthopedics, Otolaryngology, and CNS
2. OTC/Consumer Products (DIVCOM): Over-the-counter self-care products sold directly to consumers through pharmacy chains without prescription
3. Dermatological Products (MELORA): Dermocosmetics, nutraceuticals, and dermatological medications sold through pharmacy chains and prescribed by dermatologists

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Farmoquímica (FQM) is a Brazilian pharmaceutical manufacturer founded in 1932 that develops, produces, and distributes prescription medicines, dermatological products, dermocosmetics, nutraceuticals, and over-the-counter self-care products. The portfolio is sold across Brazil through three divisions: FQM FARMA (prescription drugs across multiple therapeutic specialties), FQM MELORA (dermatology, dermocosmetics, and nutraceuticals sold via dermatologists), and FQM DIVCOM (OTC consumer self-care products). Revenue is generated through one-time product sales to pharmacy chains, prescribing physicians, and end consumers, supported by a national field-sales force of more than 450 representatives.

Product overview

Farmoquímica (FQM) is a Brazilian pharmaceutical company founded in 1932 with three main business divisions: FQM FARMA (prescription-focused), FQM MELORA (dermatology with dermocosmetics, nutraceuticals, medications), and FQM DIVCOM (OTC self-care products). The product portfolio spans prescription medications across multiple therapeutic areas (cardiology, neurology, psychiatry, dermatology, infectious diseases), dermatological dermocosmetics (sunscreens like Heliomax and Heliocare, anti-aging like Tensage and Melora C, acne treatments like Dercutan and Duo Retix, moisturizers like Dermovance, and scar treatments like Kelo-cote), nutraceuticals (Eximia line for skin, hair, and nail care), and OTC consumer products (Imecap, Sedavan, Floratil, Calcitran). The company operates with over 1,600 employees, 450+ representatives for FQM FARMA, and 108 representatives for FQM MELORA, reaching thousands of doctors monthly across Brazil.

Differentiator

Problem solved

Functional benefit

Products and services

• Farmoquímica FARMA Prescription Medicine Portfolio (FQM FARMA) Branded prescription medications sold under medical prescription across multiple therapeutic specialties, including products such as Abretia (duloxetine), Annita (nitazoxanide), Bactrim (sulfonamide antibiotic), Belpele (adapalene), Dormonid (sedative), LAIO (bisoprolol), Marevan (warfarin), Prefiss (pregabalin), and Rohypnol (flunitrazepam). Indicated for use by prescribing physicians and specialists in Brazil.

Quantifiable outcome

• Reaches over 12,000 doctors monthly through MELORA division
• +1 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Eurofarma Laboratórios: One of Brazil's largest privately-held pharmaceutical companies, operating across branded generics, prescription, OTC, and hospital segments with national manufacturing and a large medical rep force — directly comparable to FQM's multi-division Brazilian pharma model.
• EMS Pharma: Brazil's largest pharmaceutical company by units sold, with deep presence in branded generics, prescription, and consumer health, and a broad medical representative network across the country — a direct competitor to FQM FARMA and FQM DIVCOM.
• Aché Laboratórios: Brazilian mid-to-large pharma with prescription, OTC, and dermocosmetic portfolios marketed through a national medical sales force — closely comparable to FQM's three-division model and prescription-dermocosmetic overlap.
• Hypera Pharma: Brazil's largest pharma by market cap with leading OTC and consumer health brands plus a strong Rx portfolio (Neo Química, Mantecorp) — comparable to FQM as a multi-channel Brazilian pharma with both ethical and consumer franchises.
• Biolab Farmacêutica: Brazilian pharmaceutical company focused on prescription, dermatology, and gynecology/obstetrics, marketed through medical representatives and specialty channels — directly comparable to FQM FARMA and FQM MELORA's specialty Rx focus.
• Mantecorp Skintech (Hyperarma unit): Brazilian dermocosmetic brand owned by Hypera, with strong dermatologist-channel distribution and premium skincare SKUs — directly comparable to FQM MELORA's dermatologist-targeted dermocosmetic strategy.

Broad incumbents

• Galderma Brazil: Global dermatology-focused pharmaceutical and skincare company with a Brazilian commercial operation covering prescription derma, aesthetics, and consumer skincare — broader portfolio than FQM MELORA but overlapping in the dermatologist channel.
• L'Oréal Brasil (La Roche-Posay / Vichy): Global beauty major with dermatologist-recommended brands (La Roche-Posay, Vichy) strongly distributed through Brazilian pharmacy chains and dermatologists — competes with FQM MELORA's Heliocare, Heliomax, and Dermovance lines in the premium skincare category.
• Bayer Brazil (Consumer Health): Multinational with a significant Brazilian pharmaceutical and consumer health business spanning prescription, OTC, and dermatology — overlaps with FQM FARMA and FQM DIVCOM in Rx and OTC categories.

Emerging players

• Grupo NC (Darrow Laboratórios): Brazilian dermatology-focused pharmaceutical group (Darrow, Aché dermatology spin-off legacy) with prescription derma and dermocosmetic brands sold through dermatologist channels — a smaller-scale emerging peer in the same FQM MELORA niche.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/TodosSomosFQM
• LinkedInlinkedin.com/company/farmoquimica-s-a
• Instagraminstagram.com/fqm_oficial?igshid=1otxo6z0s09mq

Compliance11 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Farmoquímica